|
|
|
|
|
A Novel, Inexpensive In-House Immunochromatographic Strip Test for Cryptococcosis Based on the Cryptococcal Glucuronoxylomannan Specific Monoclonal Antibody 18B7 |
2564 |
# |
|
|
|
|
|
A nuclear targeting system in Plasmodium falciparum |
2553 |
# |
|
|
|
|
|
A One Health approach to assessing occupational exposure to antimicrobial resistance in Thailand: The FarmResist project |
2564 |
# |
|
|
|
|
|
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? |
2561 |
# |
|
|
|
|
|
A patient-centric approach to optimise insulin therapy in Asia |
2559 |
# |
|
|
|
|
|
A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against Dengue virus infection. |
2558 |
# |
|
|
|
|
|
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple, Intravenous, Ascending-Dose Study of Sirukumab in Patients with Cutaneous or Systemic Lupus Erythematosus. |
2554 |
# |
|
|
|
|
|
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. |
2550 |
# |
|
|
|
|
|
A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload. |
2553 |
# |
|
|
|
|
|
A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection |
2559 |
# |
|
|
|
|
|
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age |
2564 |
# |
|
|
|
|
|
A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload |
2555 |
# |
|
|
|
|
|
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia. |
2563 |
# |
|
|
|
|
|
A Phase II Open-label Pilot Study of the Safety, Pharmacokinetics and Antiviral Activity of BIT225, a HCV p7 inhibitor, in Combination with Pegylated Interferon and Ribavirin in Patients with HCV Genotypes 1 and 3 who are Co-infected with HIV-1 |
2556 |
# |
|
|
|
|
|
A Phase II Open-label Pilot Study of the Safety, Pharmacokinetics and Antiviral Activity of BIT225, a HCV p7 inhibitor, in Combination with Pegylated Interferon and Ribavirin in Patients with HCV Genotypes 1 and 3 who are Co-infected with HIV-1 |
2556 |
# |
|
|
|
|
|
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis |
2552 |
# |
|
|
|
|
|
A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer |
2556 |
# |
|
|
|
|
|
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma. |
2562 |
# |
|
|
|
|
|
A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis. |
2549 |
# |
|
|
|
|
|
A PHASE IIA, OPEN-LABEL STUDY TO ASSESS THE ANTIVIRAL ACTIVITY OF TMC435 MONOTHERAPY IN PATIENTS INFECTED WITH HCV GENOTYPES 2-6 |
2553 |
# |
|
|
|
|
|
A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix |
2552 |
# |
|
|
|
|
|
A Pilot Comparative Study of Submerge vs. Non-Submerg Saturated Salt Solution Human Cadavers Embalming Method by Gross, Histological, and Microbiological Evaluation |
2565 |
# |
|
|
|
|
|
A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix. |
2550 |
# |
|
|
|
|
|
A pilot study - Safety and efficacy of fermented olive tree leaf extracts for chronic paronychia and Neoscytalidium dimidiatum onychomycosis treatment |
2560 |
# |
|
|
|
|
|
A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring. |
2561 |
# |
|
|
|
|
|
A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX |
2563 |
# |
|
|
|
|
|
A pilot study of a sternal closure technique to prevent postoperative pectus carinatum in congenital heart surgery pediatric patients |
2560 |
# |
|
|
|
|
|
A pilot study of the cross-reactivity between cereal grains among children with IgE-mediated wheat allergy |
2561 |
# |
|
|
|
|
|
A pilot study of treatment of striae distensae with variable square pulse Erbium: YAG laser resurfacing. |
2560 |
# |
|
|
|
|
|
A Pilot Study on Visually Stimulated Cognitive Tasks for EEG-Based Dementia Recognition |
2564 |
# |